Radnet Inc (NASDAQ: RDNT) |
|
Price: $58.8400
$1.58
2.759%
|
Day's High:
| $59.06
| Week Perf:
| 6.06 %
|
Day's Low: |
$ 57.29 |
30 Day Perf: |
6.19 % |
Volume (M): |
1,037 |
52 Wk High: |
$ 93.65 |
Volume (M$): |
$ 60,990 |
52 Wk Avg: |
$62.39 |
Open: |
$57.54 |
52 Wk Low: |
$45.00 |
|
|
Market Capitalization (Millions $) |
4,377 |
Shares
Outstanding (Millions) |
74 |
Employees |
7,872 |
Revenues (TTM) (Millions $) |
1,869 |
Net Income (TTM) (Millions $) |
4 |
Cash Flow (TTM) (Millions $) |
190 |
Capital Exp. (TTM) (Millions $) |
223 |
Radnet Inc
Radnet Inc is a leading provider of diagnostic imaging services, including MRI, CT, PET/CT, X-ray, ultrasound, and mammography. The company operates a network of outpatient radiology centers and provides radiology services to hospitals and healthcare providers nationwide.
Founded in 1985, Radnet has grown to become one of the largest providers of diagnostic imaging services in the United States. The company has over 300 imaging centers across 6 states, including California, Maryland, Delaware, New Jersey, New York, and Florida.
Radnet's services are provided by a team of board-certified radiologists, technologists, and support staff, who work together to provide the highest quality of care to their patients. The company is committed to using the latest technology and imaging techniques to ensure accurate and timely diagnoses.
In addition to its diagnostic imaging services, Radnet also provides a range of healthcare IT solutions, including radiology information systems and picture archiving and communication systems. These solutions enable healthcare providers to streamline their workflow and improve patient care.
Radnet is also committed to giving back to the communities it serves. The company sponsors various charity events and provides free imaging services to underserved populations.
Overall, Radnet is a leading provider of diagnostic imaging services, with a commitment to providing the highest quality of care to its patients through the use of the latest technology and imaging techniques.
Company Address: 1510 Cotner Avenue Los Angeles, 90025 CA
Company Phone Number: 478-7808 Stock Exchange / Ticker: NASDAQ RDNT
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Product Service News
Published Wed, Feb 26 2025 6:53 AM UTC
Unveiling Tomorrow?s Radiology: DeepHealth Pioneers AI-Powered Solutions at ECR 2025 In the realm of healthcare, the effective utilization of artificial intelligence (AI) is revolutionizing clinical and operational processes across the globe. At the forefront of this transformation is DeepHealth, Inc. a global leader in AI-powered health informatics and a wholly-owned subsid...
|
Product Service News
Published Fri, Nov 29 2024 11:00 AM UTC
Expanding Horizons in Breast Cancer Screening: DeepHealth s SmartMammo Gains Wider FDA Clearance DeepHealth, Inc. a prominent player in the realm of AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), has taken a significant stride forward in revolutionizing mammography with the expanded FDA 510(k) clearance of their SmartMammo solutio...
|
Management Announcement
Published Fri, Nov 22 2024 4:00 PM UTC
IntroductionIn a significant financial maneuver, RadNet, Inc. (NASDAQ: RDNT), a leader in outpatient diagnostic imaging services, has announced the reduction of its credit facility interest rates. This comes hand-in-hand with impressive revenue growth, highlighting RadNet s resilience and tactical positioning in the competitive healthcare landscape. Additionally, the company...
|
Partnership
Published Mon, Nov 11 2024 11:00 AM UTC
Collaborative Efforts to Transform Imaging and Promote Healthcare Equity: GE HealthCare, RadNet, and Community Initiatives Transformative Partnership in Imaging SystemsOn November 11, 2024, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc. a prominent subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a groundbreaking strategic collaboration to reshape the landscape of me...
|
Partnership
Published Thu, Sep 5 2024 10:00 AM UTC
DeepHealth and HOPPR Join Forces to Pioneer AI Advancements in Healthcare By Special Correspondence CAMBRIDGE, Mass. Sept. 05, 2024 - In an epoch where the confluence of digital intellect and medical sciences is increasingly becoming the cornerstone of modern healthcare, profound announcements heralded from the esteemed precincts of Cambridge. DeepHealth, a fully-integrated...
|
Per Share |
Current |
Earnings (TTM) |
-0.45 $ |
Revenues (TTM) |
25.13 $
|
Cash Flow (TTM) |
2.56 $ |
Cash |
10.13 $
|
Book Value |
15.28 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-0.45 $
|
Revenues (TTM) |
25.13 $ |
Cash Flow (TTM) |
2.56 $ |
Cash |
10.13 $
|
Book Value |
15.28 $ |
Dividend (TTM) |
0 $ |
|
|
|
Commercial insurance |
|
55.68 % |
of total Revenue |
Medicare |
|
22.95 % |
of total Revenue |
Medicaid |
|
2.48 % |
of total Revenue |
Workers compensation personal injury |
|
2.22 % |
of total Revenue |
Other payors |
|
5.87 % |
of total Revenue |
Management fee revenue |
|
1.33 % |
of total Revenue |
Other revenue |
|
2.66 % |
of total Revenue |
Revenue under capitation arrangements |
|
6.8 % |
of total Revenue |
Imaging Center |
|
-97.87 % |
of total Revenue |
Digital health |
|
-4.08 % |
of total Revenue |
InterEliminations |
|
1.95 % |
of total Revenue |
InterEliminations Digital health |
|
1.95 % |
of total Revenue |
|
On February 27 2025 the Radnet Inc provided following guidance
RadNet, Inc. has announced its financial results for the fourth quarter and the complete year of 2024, marking a significant milestone with record revenue and adjusted EBITDA figures. Additionally, the company has disclosed its financial projections for 2025.
On February 27, 2025, RadNet, Inc. (NASDAQ: RDNT), recognized as a national frontrunner in delivering high-quality, cost-efficient outpatient diagnostic imaging services, revealed details of its operations across a robust network of 398 imaging centers that the company owns and operates. The fourth quarter results for 2024 underscored RadNet?s strong performance, showcasing remarkable growth in both revenue and adjusted EBITDA.
While t...
|
|
|